Key result
Initial anthracycline therapy is not associated with acute troponin T elevation.
Why the study?
Does initial anthracycline therapy cause acute elevation of serum troponin T levels in adult patients without prior cardiac disease?
Observational (n=10)
Does initial anthracycline therapy cause acute elevation of serum troponin T levels in adult patients without prior cardiac disease?
Initial cycles of anthracycline therapy do not cause acute elevation of serum troponin T, suggesting that acute minimal myocardial cell disruption is unlikely to be the primary mechanism of anthracycline-induced cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
This case series does not support acute troponin elevation after initial anthracyclines; hypothesis-generating for mechanisms and should not change practice.
Raderer et al. (1997) conducted an observational in Cancer undergoing anthracycline therapy (n=10). Anthracycline therapy was evaluated on Change in serum troponin T levels. Initial anthracycline therapy in 10 adult patients did not elevate serum troponin T levels above the 0.2 ng/mL cutoff within 48 hours, suggesting acute myocardial cell damage is unlikely.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: